MUMBAI, India, June 22 -- Intellectual Property India has published a patent application (202641068289 A) filed by Sr University on June 01, 2026, for Drug Delivery Scaffold And Method For Treating Myiasis-Affected Wounds.
Inventors include Dr. Sarath Chandra Veerla; Dr. Babu Bathula; and Dr. Thirumala Rao Gurugubelli.
The application for the patent was published on June 12, 2026, under issue no. 24/2026.
Abstract: DRUG DELIVERY SCAFFOLD AND METHOD FOR TREATING MYIASIS-AFFECTED WOUNDS ABSTRACT A drug delivery scaffold (100) for treating myiasis-affected wounds is disclosed. The drug delivery scaffold (100) comprising a polymer composite matrix (104) to form a therapeutic scaffold (102), an antibacterial agent (106) incorporated within the polymer composite matrix (104), a tissue regenerative compound (108) embedded within the polymer composite matrix (104), an anti-parasitic therapeutic agent (110) for larval elimination, and a controlled-release structure (114) to release the antibacterial agent (106), the tissue regenerative compound (108), and the anti-parasitic therapeutic agent (110) in a sustained manner at a wound site (112). The drug delivery scaffold (100) provides localized therapeutic treatment, larval elimination, infection prevention, and tissue regeneration through a controlled-release therapeutic scaffold structure. The drug delivery scaffold (100) provides sustained therapeutic delivery and structural wound support for accelerated recovery of myiasis-affected tissue regions. Claims: 10, Figures: 2 Figure 1 is selected.
Disclaimer: Curated by HT Syndication.
